Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Gene Expression Profiling Identifies CAV1, CD44, and TFRC as Potential Diagnostic Markers and Therapeutic Targets for Multiple Myeloma

17 Apr 2025

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Mechanisms and Therapy
Share to Multiple Myeloma Research and Treatments
Share to Protein Degradation and Inhibitors

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 40246772
DOI: 10.1007/s12013-025-01743-0

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Gene Expression Profiling Identifies CAV1, CD44, and TFRC as Potential Diagnostic Markers and Therapeutic Targets for Multiple MyelomaPMID 40246772Read ↗

Elevated serum lncRNA TUG1 levels are a potential diagnostic biomarker of multiple myelomaSemantic proximity Read ↗

Molecular pathogenesis of multiple myeloma: basic and clinical updatesSemantic proximity Read ↗

IRF4 in multiple myeloma—Biology, disease and therapeutic targetSemantic proximity Read ↗

Integrative network analysis identifies novel drivers of pathogenesis and progression in newly diagnosed multiple myelomaSemantic proximity Read ↗

miRNAs driving diagnosis, progression, and drug resistance in multiple myelomaSemantic proximity Read ↗

Gene Expression Profiles in Myeloma: Ready for the Real World?Semantic proximity Read ↗

Gene profiling of lymphoma, myeloma, and AML.Semantic proximity Read ↗

Gene expression profiling for molecular classification of multiple myeloma in newly diagnosed patientsSemantic proximity Read ↗

Highly expressed genes in multiple myeloma cells – what can they tell us about the disease?Semantic proximity Read ↗

Genetics and molecular profiling of multiple myeloma: Novel tools for clinical management?Semantic proximity Read ↗

Decoding the role of miRNAs in multiple myeloma pathogenesis: A focus on signaling pathwaysSemantic proximity Read ↗

Soluble MICA as an independent prognostic factor for the overall survival and progression-free survival of multiple myeloma patientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.